Copyright Reports & Markets. All rights reserved.

Global Cystic Fibrosis Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 CFTR
      • 1.4.3 Mucolytics
      • 1.4.4 PERT
      • 1.4.5 Anti-infectives
      • 1.4.6 Bronchodilators
    • 1.5 Market by Application
      • 1.5.1 Global Cystic Fibrosis Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cystic Fibrosis Therapeutics Market Size
    • 2.2 Cystic Fibrosis Therapeutics Growth Trends by Regions
      • 2.2.1 Cystic Fibrosis Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Cystic Fibrosis Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Cystic Fibrosis Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Cystic Fibrosis Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Cystic Fibrosis Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cystic Fibrosis Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Cystic Fibrosis Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Cystic Fibrosis Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cystic Fibrosis Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Cystic Fibrosis Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Cystic Fibrosis Therapeutics Market Size (2014-2019)
    • 5.2 Cystic Fibrosis Therapeutics Key Players in United States
    • 5.3 United States Cystic Fibrosis Therapeutics Market Size by Type
    • 5.4 United States Cystic Fibrosis Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Cystic Fibrosis Therapeutics Market Size (2014-2019)
    • 6.2 Cystic Fibrosis Therapeutics Key Players in Europe
    • 6.3 Europe Cystic Fibrosis Therapeutics Market Size by Type
    • 6.4 Europe Cystic Fibrosis Therapeutics Market Size by Application

    7 China

    • 7.1 China Cystic Fibrosis Therapeutics Market Size (2014-2019)
    • 7.2 Cystic Fibrosis Therapeutics Key Players in China
    • 7.3 China Cystic Fibrosis Therapeutics Market Size by Type
    • 7.4 China Cystic Fibrosis Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Cystic Fibrosis Therapeutics Market Size (2014-2019)
    • 8.2 Cystic Fibrosis Therapeutics Key Players in Japan
    • 8.3 Japan Cystic Fibrosis Therapeutics Market Size by Type
    • 8.4 Japan Cystic Fibrosis Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cystic Fibrosis Therapeutics Market Size (2014-2019)
    • 9.2 Cystic Fibrosis Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Cystic Fibrosis Therapeutics Market Size by Type
    • 9.4 Southeast Asia Cystic Fibrosis Therapeutics Market Size by Application

    10 India

    • 10.1 India Cystic Fibrosis Therapeutics Market Size (2014-2019)
    • 10.2 Cystic Fibrosis Therapeutics Key Players in India
    • 10.3 India Cystic Fibrosis Therapeutics Market Size by Type
    • 10.4 India Cystic Fibrosis Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cystic Fibrosis Therapeutics Market Size (2014-2019)
    • 11.2 Cystic Fibrosis Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Cystic Fibrosis Therapeutics Market Size by Type
    • 11.4 Central & South America Cystic Fibrosis Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Vertex Pharmaceuticals
      • 12.1.1 Vertex Pharmaceuticals Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cystic Fibrosis Therapeutics Introduction
      • 12.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2014-2019)
      • 12.1.5 Vertex Pharmaceuticals Recent Development
    • 12.2 F. Hoffmann-La Roche
      • 12.2.1 F. Hoffmann-La Roche Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cystic Fibrosis Therapeutics Introduction
      • 12.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2014-2019)
      • 12.2.5 F. Hoffmann-La Roche Recent Development
    • 12.3 AbbVie
      • 12.3.1 AbbVie Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cystic Fibrosis Therapeutics Introduction
      • 12.3.4 AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2014-2019)
      • 12.3.5 AbbVie Recent Development
    • 12.4 Gilead Sciences
      • 12.4.1 Gilead Sciences Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cystic Fibrosis Therapeutics Introduction
      • 12.4.4 Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2014-2019)
      • 12.4.5 Gilead Sciences Recent Development
    • 12.5 Novartis
      • 12.5.1 Novartis Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cystic Fibrosis Therapeutics Introduction
      • 12.5.4 Novartis Revenue in Cystic Fibrosis Therapeutics Business (2014-2019)
      • 12.5.5 Novartis Recent Development
    • 12.6 AstraZeneca
      • 12.6.1 AstraZeneca Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cystic Fibrosis Therapeutics Introduction
      • 12.6.4 AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2014-2019)
      • 12.6.5 AstraZeneca Recent Development
    • 12.7 Bayer
      • 12.7.1 Bayer Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Cystic Fibrosis Therapeutics Introduction
      • 12.7.4 Bayer Revenue in Cystic Fibrosis Therapeutics Business (2014-2019)
      • 12.7.5 Bayer Recent Development
    • 12.8 Celtaxsys
      • 12.8.1 Celtaxsys Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Cystic Fibrosis Therapeutics Introduction
      • 12.8.4 Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2014-2019)
      • 12.8.5 Celtaxsys Recent Development
    • 12.9 Pharmaxis
      • 12.9.1 Pharmaxis Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Cystic Fibrosis Therapeutics Introduction
      • 12.9.4 Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2014-2019)
      • 12.9.5 Pharmaxis Recent Development
    • 12.10 ProQR Therapeutics
      • 12.10.1 ProQR Therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Cystic Fibrosis Therapeutics Introduction
      • 12.10.4 ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2014-2019)
      • 12.10.5 ProQR Therapeutics Recent Development
    • 12.11 PTC Therapeutics
    • 12.12 Alcresta Therapeutics
    • 12.13 Insmed Incorporated
    • 12.14 Savara
    • 12.15 Cyclacel Pharmaceuticals
    • 12.16 Vectura
    • 12.17 Allergan

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Cystic Fibrosis Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Cystic Fibrosis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cystic Fibrosis Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Vertex Pharmaceuticals
      F. Hoffmann-La Roche
      AbbVie
      Gilead Sciences
      Novartis
      AstraZeneca
      Bayer
      Celtaxsys
      Pharmaxis
      ProQR Therapeutics
      PTC Therapeutics
      Alcresta Therapeutics
      Insmed Incorporated
      Savara
      Cyclacel Pharmaceuticals
      Vectura
      Allergan

      Market segment by Type, the product can be split into
      CFTR
      Mucolytics
      PERT
      Anti-infectives
      Bronchodilators

      Market segment by Application, split into
      Hospitals
      Clinics

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Cystic Fibrosis Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Cystic Fibrosis Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Cystic Fibrosis Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now